21200 ⎘
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant; Organic adjuvants Saponins; Quil A; QS21; ISCOMS
BREAST CANCER VACCINE
#2NOVEL ADJUVANT FOR ANIMAL AND HUMAN VACCINES
#3HIV Immunogens, Vaccines, and Methods Related Thereto
#4TRITERPENE SAPONIN ANALOGUES
#5VACCINES
#6CORONAVIRUS VACCINE FORMULATIONS
#7Methods for the Rapid Manufacture of Conjugate Vaccines that Elicit Robust Immune Responses
#8METHODS AND COMPOSITIONS RELATING TO THE SYNTHESIS OF THE QS-7 MOLECULE
#9PNEUMOCOCCAL CONJUGATE VACCINES WITH SAPONIN-BASED ADJUVANTS
#10VIRUS-LIKE VESICLES (VLVS) BASED VACCINES AND METHODS OF PREVENTING, AMELIORATING, AND/OR TREATING COVID-19 AND/OR HEPATOCELLULAR CARCINOMA (HCC)
#11VACCINES TARGETING C. ACNES HYALURONIDASE FOR PROPHYLAXIS AND TREATMENT OF ACNE VULGARIS
#12ENVELOPED VIRUS LIKE PARTICLES COMRISING SARS-COV-2 S PROTEIN
#13RSV VACCINATION WITH TRIMERIC RSV F FUSION PROTEIN
#14INJECTABLE HYDROGELS FOR CONTROLLED RELEASE OF IMMUNOMODULATORY COMPOUNDS
#15CANCER ANTIGENS AND METHODS
#16COMPOSITIONS, METHODS AND USES FOR ELICITING AN IMMUNE RESPONSE
#17VACCINE ADJUVANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#18Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections
#19COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST EPSTEIN-BARR VIRUS
#20Veterinary Vaccine Composition Against Parasitic Worms, Method for Treating and Preventing Infection by Parasitic Worms, and Use
#21SAPONIN-BASED IMMUNOSTIMULANTS, PHARMACEUTICAL COMPOSITION COMPRISING SAID IMMUNOSTIMULANTS, THERAPEUTIC USE THEREOF
#22ADJUVANT COMPOSITION, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE CAUSED BY VIRAL INFECTION, BACTERIAL INFECTION, PROTOZOAL INFECTION OR CANCER
#23Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
#24STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS
#25ENTEROCOCCUS FAECALIS VACCINE AND USES THEREOF
#26MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF
#27RESPIRATORY SYNCYTIAL VIRUS RECOMBINANT FUSION PROTEIN WITH PRE-FUSION CONFORMATION, PREPARATION METHOD AND USES THEREOF
#28BIOSYNTHESIS
#29MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#30CELL-BASED VACCINES
#31METHODS FOR PRODUCING AN ADJUVANT
#32Multivalent Vaccine Compositions
#33PEPTIDE CONJUGATE VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#34INTRANASAL IMMUNOGENIC COMPOSITIONS
#35HIV VACCINE IMMUNOGENS
#36SAPONIN-BASED ADJUVANTS AND METHODS OF CHARACTERIZING SAME
#37DNA VACCINE AGAINST LEISHMANIASIS
#38HYPERACTIVATING LIPID NANOPARTICLES
#39VACCINE FOR EQUINE HERPESVIRUS
#40OIL-BASED ADJUVANTS
#41MODIFIED HUMAN CYTOMEGALOVIRUS PROTEINS
#42SAPONIN-BASED ADJUVANTS AND VACCINES
#43FREEZE-DRIED VIRAL COMBINATION VACCINE COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF
#44CORONAVIRUS VACCINE FORMULATIONS
#45MALARIA VACCINE FORMULATIONS
#46METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA
#47HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS
#48SARS-COV-2 VACCINE COMPOSITIONS
#49INTERLEUKIN-1 ALPHA CHIMERIC PROTEIN
#50Novel Adjuvant Compositions
#51Multi-epitope vaccine for the treatment of Alzheimer's disease
#52VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME
#53CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM
#54SARS-COV-2 SUBUNIT VACCINE
#55SUBUNIT VACCINES WITH DINUCLEOTIDE-LOADED HYDROGEL ADJUVANT
#56NOVEL METHODS FOR MANUFACTURING AN ADJUVANT
#57ADJUVANT AND VACCINE CONTAINING ADJUVANT
#58HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#59ANTI-TUMOR COMPOSITIONS AND USES THEREOF
#60CORONAVIRUS VACCINE FORMULATIONS
#61OPTIMAL PRODUCTION OF SARS-COV-2 VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN MAMMALIAN CELLS
#62COMPOSITION FOR IN VIVO DELIVERY OF RNA AND PREPERATION METHOD THEREFOR
#63ADJUVANT FOR ANIMAL AND HUMAN VACCINES
#64FORMULATIONS AND METHODS FOR MHC-I RESTRICTED EPITOPE IMMUNIZATION
#65ADJUVANT COMPRISING A GLYCOARCHAEOL AND AN IMMUNOSTIMULANT
#66BREAST CANCER VACCINE
#67NOVEL TRYPANOSOMAL VACCINE
#68Vaccine Composition for Preventing Tuberculosis Comprising Chorismate Mutase
#69MODIFICATION OF SAPONINS
#70Quil A fraction with low toxicity and use thereof
#71SAPONIN EXTRACTION
#72Combined Preparation
#73Oil-based adjuvants
#74ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE
#75TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS
#76Saponin extraction
#77SINGLE-CHAIN CORONAVIRUS VIRAL MEMBRANE PROTEIN COMPLEXES
#78DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING BETA-GLUCAN AS A VACCINE ADJUVANT
#79CORONAVIRUS VACCINE FORMULATIONS
#80Multi-epitope vaccine for the treatment of Alzheimer's disease
#81Filamentous nanoparticles having vaccine adjuvant effect
#82Multi-epitope vaccine for the treatment of Alzheimer's disease
#83SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS
#84Multi-epitope vaccine for the treatment of Alzheimer's disease
#85PURIFIED SAPONINS AND CHROMATOGRAPHIC PROCESS FOR PURIFICATION OF SAME
#86Saponin purification
#87AMHR2-ED CANCER VACCINE FORMULATIONS
#88Recombinant HIV-1 envelope proteins and their use
#89IMMUNOGENIC COMPOSITIONS AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE AND METHODS THEREOF
#90Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
#91MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME
#92FOOT-AND-MOUTH DISEASE VIRUS-LIKE PARTICLE ANTIGEN, VACCINE COMPOSITION, PREPARATION METHOD, AND USE THEREOF
#93Vaccine for prevention of necrotic enteritis in poultry
#94ADJUVANT COMPOUNDS, SALT FORMS, AND FORMULATIONS
#95VARICELLA ZOSTER VIRUS FUSION PROTEIN AND IMMUNOGENIC COMPOSITION COMPRISING SAME
#96Methods and composition for induction of immune response
#97STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY
#98PHARMACEUTICAL COMPOSITION AND USE THEREOF
#99PHARMACEUTICAL COMPOSITION AND USE THEREOF
#100DRY LIPOSOME ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF
#101TREATMENT METHODS
#102PARTICLES FOR MULTI-DOSE DELIVERY
#103HIV Immunogens, Vaccines, and Methods Related Thereto
#104CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM
#105METHODS FOR MANUFACTURING AN ADJUVANT
#106CORONAVIRUS VACCINE FORMULATIONS
#107Minimal saponin analogues, synthesis and use thereof
#108ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER
#109Vaccine Adjuvants for Antigen Delivery
#110SAPONIN PURIFICATION
#111Subunit vaccine of contagious caprine pleuropneumonia and preparation method and use thereof
#112PEPTIDES AND CONJUGATES FOR TREATMENT OF ARTHRITIS
#113Methods and compositions for inducing immune responses against
#114TRITERPENE SAPONIN ANALOGUES
#115NOVEL INFLUENZA ANTIGENS
#116MULTI-VALENT IMMUNOTHERAPY COMPOSITION AND METHODS OF USE FOR TREATING WT1-POSITIVE CANCERS
#117recombinanr xiexumapoeozoite protein compositions and method for vaccine delivery
#118COMPOSITION AND PROCESS FOR PREPARING VACCINE
#119SAPONIN-BASED VACCINE ADJUVANTS
#120Corona virus vaccine formulations
#121Foot-and-mouth disease virus-like particle antigen, and vaccine composition, preparation method, and application thereof
#122Trypanosomal vaccine
#123COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE
#124COMPOSITIONS, METHODS AND USES FOR ELICITING AN IMMUNE RESPONSE
#125Immunological adjuvant composition, preparation method and application thereof
#126Anti-coronavirus vaccines
#127HIV vaccine immunogens
#128Vaccine for prevention of necrotic enteritis in poultry
#129METHOD FOR MANUFACTURING A TUMOR VACCINE
#130Cancer antigens and methods
#131Adjuvant compositions
#132INJECTABLE HYDROGELS FOR CONTROLLED RELEASE OF IMMUNOMODULATORY COMPOUNDS
#133Optimized Zika virus envelope gene and expression thereof
#134Boosting immunogenicity of vaccines using saponins and agonists of the intracellular stimulator of interferon genes pathway
#135TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS
#136RECOMBINANT BIOLOGICALLY CONTAINED FILOVIRUS VACCINE
#137TRITERPENE SAPONIN ANALOGUES
#138ANTI-TUMOR COMPOSITIONS AND USES THEREOF
#139METHODS AND COMPOSITIONS FOR TREATING CANCERS
#140Vaccine composition and uses thereof
#141COMPOSITION AND PROCESS FOR PREPARING VACCINE
#142Coronavirus vaccine formulations
#143Coronavirus vaccine formulations
#144Multi-epitopic peptide compounds and vaccines against leishmaniasis
#145Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof
#146Oil-based adjuvants
#147Methods for manufacturing an adjuvant
#148Hepatitis B immunization regimen and compositions
#149Composition, preparation method and evaluation of a complex immunogen named I-SPGA for production of immunological active proteins (IAP)
#150Methods for inducing an immune response
#151RECOMBINANT FUSION PROTEIN AND IMMUNOGENIC COMPOSITION
#152Minimal saponin analogues, synthesis and use thereof
#153IMMUNOTHERAPEUTIC COMPOSITIONS
#154SAPONIN-BASED VACCINE ADJUVANTS
#155Saponin adjuvant and evaluation method thereof
#156Immunogenic composition comprising staphylococcal antigens
#157Immunotherapy of leishmaniasis
#158Lipid nanoparticle vaccine adjuvants and antigen delivery systems
#159Mucosal adjuvants and delivery systems
#160Adjuvant for animal and human vaccines
#161Dried composition of saponin in a liposomal formulation with a neutral lipid, a sterol, and a cryoprotectant
#162Vaccines comprising polypeptides for the prevention, treatment, and diagnosis of leprosy
#163UspA2 protein constructs and uses thereof
#164Saponin extraction
#165Composition comprising iscom particles and live micro-organisms
#166Saponin purification
#167Methods for inducing an immune response
#168Triterpene saponin analogues
#169Use of adjuvants for the prevention and/or treatment of autoimmune diseases
#170VACCINES FOR TREATMENT AND PREVENTION OF CANCER
#171Vaccine for prevention of necrotic enteritis in poultry
#172ISCOM PREPARATION AND USE THEREOF
#173Dried composition
#174TRITERPENE SAPONIN ANALOGUES
#175Immunogenic compositions for the prevention and treatment of meningococcal disease
#176Non-lipidated variants of ORF2086 antigens
#177Vaccine against necrotic enteritis in poultry
#178Methods and compositions for inducing immune responses against Clostridium difficile
#179Method of making a liposome composition
#180Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
#181Breast cancer vaccine
#182Financial Method
#183Methods for inducing an immune response
#184Recombinant HIV-1 envelope proteins and their use
#185Influenza vaccine
#186Recombinant prefusion RSV F proteins and uses thereof
#187Method for preventing or treating infection
#188West nile virus vaccine and method of use thereof
#189IPSC-based vaccine as a prophylactic and therapeutic treatment for cancer
#190Adjuvant compositions
#191Methods and compositions for inducing an immune response
#192VACCINES AGAINST INTRA-ABDOMINAL INFECTIONS
#193VACCINES AGAINST URINARY TRACT INFECTIONS
#194Mucosal adjuvants and delivery systems
#195Human rhinovirus vaccine
#196Adjuvant compositions and related methods
#197Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#198Immunogenic WT-1 peptides and methods of use thereof
#199Influenza antigens
#200Oil-based adjuvants
#201Method for preventing or treating infection
#202Influenza virus vaccines and uses thereof
#203Triterpene saponin variants, methods of synthesis and use thereof
#204Adjuvant compositions
#205ANTIBODIES AGAINST IMMUNOGENIC GLYCOPEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USE THEREOF
#206Composition comprising iscom particles and live micro-organisms
#207Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
#208Dried saponin liposomal composition
#209UspA2 protein constructs and uses thereof
#210Oil-in-water emulsion influenza vaccine
#211Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#212vaccine composition
#213Polymer conjugate vaccines
#214Methods and compositions for treating herpes
#215antigenic composition
#216COMPOSITION AND USES THEREOF
#217Immunogenic/therapeutic glycan compositions and uses thereof
#218ADJUVANT COMPOSITIONS COMPRISING A NON-IONIC ISOTONICITY AGENT
#219Methods and compositions for induction of immune response
#220VACCINATION
#221Dengue virus vaccine compositions and methods of use thereof
#222VACCINE COMPOSITIONS CONTAINING MODIFIED ZIKA VIRUS ANTIGENS
#223MODIFICATION OF RECOMBINANT ADENOVIRUS WITH IMMUNOGENIC PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES
#224Immunogenic composition
#225Immunogenic WT-1 peptides and methods of use thereof
#226Non-lipidated variants of ORF2086 antigens
#227Adjuvant compositions
#228Cancer immunotherapy by immune activation or immune modulation via Globo series antigens
#229Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#230Oil-in-water emulsion influenza vaccine
#231Recombinant HIV-1 envelope proteins and their use
#232VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION
#233Vaccine for PCV2 and mycoplasma
#234Influenza virus vaccines and uses thereof
#235Adjuvant compositions and related methods
#236Method for preventing or treating infection
#237Method and compositions
#238Influenza virus vaccines and uses thereof
#239Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing liposome composition and a saponin
#240Immunogenic compositions for the prevention and treatment of meningococcal disease
#241Mucosal adjuvants and delivery systems
#242IMMUNOGENIC GLYCOPEPTIDES, COMPOSITION COMPRISING THE GLYCOPEPTIDES AND USE THEREOF
#243Methods for inducing an immune response
#244Methods for inducing an immune response
#245Minimal saponin analogues, synthesis and use thereof
#246Swarm immunization with envelopes from CH505
#247Vaccine compositions comprising a saponin adjuvant
#248Compositions and methods
#249Method for preventing or treating infection
#250ANTI-TUMOR COMPOSITIONS AND USES THEREOF
#251UspA2 protein constructs and uses thereof
#252Lipid nanoparticle vaccine adjuvants and antigen delivery systems
#253Dock-and-Lock (DNL) Vaccines for Cancer Therapy
#254composition and methods thereof
#255Type III secretion injectisome proteins for treatment and prevention of chlamydial infections
#256IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF
#257HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS
#258Vaccines for treatment and prevention of cancer
#259Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#260Multivalent breast cancer vaccine
#261Adjuvant compositions and related methods
#262Soluble HIV-1 envelope glycoprotein trimers
#263Soluble HIV-1 envelope glycoprotein trimers
#264Vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific T-cell responses
#265Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
#266Polyvalent conjugate vaccine for cancer
#267AUTOLOGOUS CANCER CELL VACCINE
#268FMDV recombinant vaccines and uses thereof
#269Mycobacterium Antigenic Composition
#270Glycan conjugates and methods of use thereof
#271Fowl adenovirus vaccine
#272Vaccine
#273QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF
#274Compositions and methods
#275Glycan conjugates and use thereof
#276Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response
#277Dengue virus vaccine compositions and methods of use thereof
#278Adjuvant compositions and related methods
#279Composition and uses thereof
#280Compositions comprising iscom particles and live micro-organisms
#281Breast cancer vaccine
#282Vaccine for PCV2 and mycoplasma
#283Recombinant subunit dengue virus vaccine
#284Immunogenic compositions containing H7 flagella and methods of use thereof
#285Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
#286Vaccine against Rhipicephalus ticks
#287Neisseria meningitidis compositions and methods thereof
#288METHOD FOR TREATING A beta-AMYLOIDOSIS
#289IN VIVO EFFICACY OF NY-ESO-1 PLUS ADJUVANT
#290Immunogenic compositions for the prevention and treatment of meningococcal disease
#291Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
#292VACCINATION ADJUVANT, PREPARATION AND VACCINES CONTAINING THE SAME
#293Immunogenic composition
#294METHOD FOR TREATING A SYNUCLEIOPATHY
#295Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
#296COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MALIGNANT GLIOMAS
#297Method for preventing or treating infection
#298Immunogenic compositions for the prevention and treatment of meningococcal disease
#299ISCOM preparation and use thereof
#300Vaccine formulations comprising saponin-containing adjuvants